On the evening of August 27, Yifan Pharmaceutical announced that SciGen Pte.Ltd., a wholly-owned subsidiary of the company, received a marketing registration approval from the Ministry of Health and Social Security of Tajikistan on August 26, approving the marketing and sale of the company's chemical product oxytocin injection in Tajikistan.

Zhitongcaijing · 08/27/2025 13:33
On the evening of August 27, Yifan Pharmaceutical announced that SciGen Pte.Ltd., a wholly-owned subsidiary of the company, received a marketing registration approval from the Ministry of Health and Social Security of Tajikistan on August 26, approving the marketing and sale of the company's chemical product oxytocin injection in Tajikistan.